Share
4,133 Posts.
lightbulb Created with Sketch. 496
clock Created with Sketch. 16/08/23
07:12
Share
Originally posted by RedStar55:
↑
Their last cap raise over $1 was off the back of the Covid hype when the share price went to $1.5. I’d say that was genius. This is a family owned business and they’re still very active grandfathers life work. Their interests are very much aligned to ours: get what appears a breakthrough product to market as quickly and with as little dilution as possible. They are doing some things in this quest that have some real downside eg free trials they can’t control and pivoting freely as they see a better route, but compared to the other clinical trial stage bios I hold, their sp is doing multiples better. Go Recce. Would love to see a truly Aussie product make a global difference and think we have a real chance.
Expand
i reckon we must be due for an update on the diabetic ulcer trial all the fast infusion trial cohorts must also be finished?
(20min delay)